跳到正文
MarketHOT
English
原文
Seeking Alpha · 市场快讯·· 7 天前AI 评分37

Kalaris Therapeutics, Inc. Q3 GAAP EPS of -$0.46 beats by $0.05

Kalaris Therapeutics, Inc. GAAP EPS of -$0.46 beats by $0.05

AI 导读

Kalaris Therapeutics, Inc. Q3 GAAP EPS of -$0.46 beats by $0.05. As of September 30, 2026, the company had cash, cash equivalents and marketable securities of $82.9M.

来源:Seeking Alpha · 市场快讯 · seekingalpha.com